Overview

OnabotulinumtoxinA for Trigeminal Neuralgia

Status:
RECRUITING
Trial end date:
2026-09-01
Target enrollment:
Participant gender:
Summary
A randomized controlled trial comparing Onabotulinumtoxin A to saline (placebo) for Trigeminal Neuralgia.
Phase:
PHASE4
Details
Lead Sponsor:
Stanford University
Treatments:
Botulinum Toxins, Type A
Injections
Sodium Chloride